These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3349463)

  • 1. Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells.
    Fernandes DJ; Smith-Nanni C; Paff MT; Neff TA
    Cancer Res; 1988 Apr; 48(7):1850-5. PubMed ID: 3349463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA.
    Fernandes DJ; Danks MK; Beck WT
    Biochemistry; 1990 May; 29(17):4235-41. PubMed ID: 2163274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
    Chen M; Beck WT
    Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II cleavable complex formation within DNA loop domains.
    Lambert JM; Fernandes DJ
    Biochem Pharmacol; 2000 Jul; 60(1):101-9. PubMed ID: 10807951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
    Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity.
    Qiu J; Catapano CV; Fernandes DJ
    Biochemistry; 1996 Dec; 35(50):16354-60. PubMed ID: 8973211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26.
    Catapano CV; Carbone GM; Pisani F; Qiu J; Fernandes DJ
    Biochemistry; 1997 May; 36(19):5739-48. PubMed ID: 9153414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase II isozymes involved in anticancer drug action and resistance.
    Fernandes DJ; Qiu J; Catapano CV
    Adv Enzyme Regul; 1995; 35():265-81. PubMed ID: 7572348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular distribution of the alpha and beta topoisomerase II-DNA complexes stabilized by VM-26.
    Danks MK; Qiu J; Catapano CV; Schmidt CA; Beck WT; Fernandes DJ
    Biochem Pharmacol; 1994 Nov; 48(9):1785-95. PubMed ID: 7980648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
    Kim R; Beck WT
    Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of DNA with the nuclear lamina in Ehrlich ascites tumor cells.
    Krachmarov C; Iovcheva C; Hancock R; Dessev G
    J Cell Biochem; 1986; 31(1):59-74. PubMed ID: 3722277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
    Chitambar CR; Wereley JP
    Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
    Hedley D; Rugg C; Musgrove E; Taylor I
    J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH; Castora FJ
    Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia blocks DNA processing at the nuclear matrix.
    Warters RL
    Radiat Res; 1988 Aug; 115(2):258-72. PubMed ID: 3406367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effects of ciprofloxacin and the topoisomerase II inhibitors, m-AMSA and nalidixic acid, on DNA repair in cultured rat liver cells.
    Rosen JE; Schluter G; Williams GM
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):254-63. PubMed ID: 8887441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of replication foci and nuclear matrix during S phase in Allium cepa L. cells.
    Samaniego R; de la Torre C; Moreno Díaz de la Espina S
    Planta; 2002 Jun; 215(2):195-204. PubMed ID: 12029468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of aphidicolin and other inhibitors on topoisomerase II-directed cytotoxic drugs.
    Haldane A; Finlay GJ; Baguley BC
    Oncol Res; 1993; 5(3):133-8. PubMed ID: 8260750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.